Offer details and timeline
Quantum Leap Acquisition Corp said it priced an initial public offering of 20 million units at $10.00 apiece, producing $200 million in proceeds before expenses. Each unit is composed of one Class A ordinary share and one redeemable warrant, and each such warrant grants the holder the right to buy one Class A ordinary share at an exercise price of $11.50.
The company expects the units to begin trading on the New York Stock Exchange under the ticker symbol "QLEPU" on May 1, 2026. Subject to standard closing conditions, Quantum Leap anticipates the offering will close on May 4, 2026. When the securities commence separate trading, the ordinary shares will trade under the symbol "QLEP" and the warrants under "QLEPW."
Underwriting and over-allotment
A.G.P./Alliance Global Partners is acting as the sole book-running manager for the offering. The underwriters have been granted a 45-day option to purchase up to 3 million additional units at the IPO price to cover any over-allotments.
Business purpose and geographic exclusions
Quantum Leap is structured as a blank check company formed to seek mergers, acquisitions, or similar business combinations. The company has stated its intention to focus acquisition efforts on targets operating in the sectors of artificial intelligence, quantum computing, and blockchain technology. The company explicitly excludes potential targets with operations in China, Hong Kong, Taiwan, and Macau.
Leadership and regulatory status
The company’s executive team includes Kervin Pillay as chief executive officer, Haydar Haba serving as chairman and chief financial officer, and David James Chapman as chief operating officer. The Securities and Exchange Commission declared the company’s registration statement on Form S-1 effective on April 30, 2026.
What the filing reveals
The prospectus details the unit composition, pricing, listing plans, underwriting arrangements and management composition. It also discloses the company’s targeted technology sectors and its geographic exclusions, and confirms the SEC effectiveness date for the registration statement.
Investors and market participants should note the offering structure, the warrant exercise price, the existence of an over-allotment option, and the company’s stated sector and regional focus when evaluating the securities.